Advanced Hybrid Closed Loop users' satisfaction of telemedicine and telenursing in pediatric and young adult type 1 diabetes.
Advanced Hybrid Closed Loop
continuous glucose monitoring
insulin infusion set
telemedicine
telenursing
type 1 diabetes mellitus
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
28
06
2023
accepted:
14
08
2023
medline:
18
9
2023
pubmed:
15
9
2023
entrez:
15
9
2023
Statut:
epublish
Résumé
The aim of the study was to evaluate the satisfaction of the use of telemedicine and telenursing in children and young adults with Type 1 Diabetes (T1D) using Advanced Hybrid Closed Loop systems (AHCL) with a focus on the role of connectivity, data download and the ease of technical steps in the set and sensor change procedures. An online anonymous survey was administered to AHCL users. The questionnaire consisted of five Clusters: Cluster A-B-C included questions related to the general satisfaction in the use of telemedicine, Cluster D was focused on the role of data download and connectivity, Cluster E was related to satisfaction in telenursing and Cluster F to the perception of ease of execution of the technical steps like changing the infusion set and the sensor. We collected 136 completed questionnaires. 83.8% of AHCL users were overall satisfied with the quality of the telemedicine service. 88.2% of patients downloaded AHCL data before visits and the overall quality of televisits (data sharing, connectivity, ease of use) was satisfactory for 85.3% of users. Telenursing support during set and sensor change procedures was considered effective by 98% of AHCL users. The sensor and insulin infusion set change procedure is perceived as different for the two systems: set change simpler for Medtronic ( Telemedicine and telenursing have an essential role in diabetology and are highly appreciated in AHCL users. The nurse support in the education of the use of AHCL systems is effective and must be implemented. Unfortunately, not all patients have the technological tools needed for downloading data at home and using telemedicine services; this represents an important challenge for the future of diabetology and for the equity in accessibility to care.
Sections du résumé
Background and aims
The aim of the study was to evaluate the satisfaction of the use of telemedicine and telenursing in children and young adults with Type 1 Diabetes (T1D) using Advanced Hybrid Closed Loop systems (AHCL) with a focus on the role of connectivity, data download and the ease of technical steps in the set and sensor change procedures.
Methods
An online anonymous survey was administered to AHCL users. The questionnaire consisted of five Clusters: Cluster A-B-C included questions related to the general satisfaction in the use of telemedicine, Cluster D was focused on the role of data download and connectivity, Cluster E was related to satisfaction in telenursing and Cluster F to the perception of ease of execution of the technical steps like changing the infusion set and the sensor.
Results
We collected 136 completed questionnaires. 83.8% of AHCL users were overall satisfied with the quality of the telemedicine service. 88.2% of patients downloaded AHCL data before visits and the overall quality of televisits (data sharing, connectivity, ease of use) was satisfactory for 85.3% of users. Telenursing support during set and sensor change procedures was considered effective by 98% of AHCL users. The sensor and insulin infusion set change procedure is perceived as different for the two systems: set change simpler for Medtronic (
Conclusion
Telemedicine and telenursing have an essential role in diabetology and are highly appreciated in AHCL users. The nurse support in the education of the use of AHCL systems is effective and must be implemented. Unfortunately, not all patients have the technological tools needed for downloading data at home and using telemedicine services; this represents an important challenge for the future of diabetology and for the equity in accessibility to care.
Identifiants
pubmed: 37711248
doi: 10.3389/fpubh.2023.1249299
pmc: PMC10497768
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1249299Informations de copyright
Copyright © 2023 Bassi, Dufour, Strati, Franzone, Scalas, Lionetti, Spacco, Rizza, Sburlati, Casalini, Parodi, d’Annunzio and Minuto.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
JMIR Nurs. 2022 Oct 4;5(1):e37631
pubmed: 36194466
Rev Esc Enferm USP. 2021 Nov 24;55:e20210295
pubmed: 34825697
Br J Haematol. 2021 Jan;192(2):e48-e51
pubmed: 33222149
Diabetes Care. 2020 Feb;43(2):337-342
pubmed: 31831473
J Clin Res Pediatr Endocrinol. 2020 Oct 21;13(4):468-472
pubmed: 33084289
J Pediatr (Rio J). 2022 Nov-Dec;98(6):587-589
pubmed: 35276099
Diabetes Technol Ther. 2022 Feb;24(2):136-139
pubmed: 34524008
Res Nurs Health. 2006 Oct;29(5):489-97
pubmed: 16977646
Pediatr Diabetes. 2021 Dec;22(8):1115-1119
pubmed: 34741569
Diabetes Technol Ther. 2016 Jan;18(1):7-14
pubmed: 26295939
Arch Dis Child. 2006 Dec;91(12):956-9
pubmed: 17119071
Diabetes Technol Ther. 2021 Sep;23(9):642-651
pubmed: 33851873
Diabetes Technol Ther. 2021 Nov;23(11):731-736
pubmed: 34115956
Pediatr Diabetes. 2022 Dec;23(8):1229-1242
pubmed: 36120721
Int J Nurs Stud. 2018 Apr;80:29-35
pubmed: 29353709
Front Public Health. 2022 Mar 22;10:857561
pubmed: 35392480
JMIR Mhealth Uhealth. 2021 Apr 5;9(4):e24374
pubmed: 33571104
J Pers Med. 2023 Jan 28;13(2):
pubmed: 36836469
Life (Basel). 2023 Mar 14;13(3):
pubmed: 36983941
Diabetes Technol Ther. 2016 Jun;18(6):385-90
pubmed: 27196443
J Pers Med. 2023 Jan 22;13(2):
pubmed: 36836432
Pediatr Diabetes. 2022 Dec;23(8):1373-1389
pubmed: 36464988
Exp Clin Endocrinol Diabetes. 2021 Nov;129(11):831-836
pubmed: 32380561
Pediatr Diabetes. 2020 Nov;21(7):1083-1092
pubmed: 32686287
Diabetes Technol Ther. 2022 Jan;24(1):67-74
pubmed: 34524007
JMIR Pediatr Parent. 2021 Feb 24;4(1):e22696
pubmed: 33556030